BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $10.4M invested in Barinthus Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.55% less ownership
Funds ownership: 23.08% → 22.53% (-0.55%)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$37.5K | |
| 2 | +$25K | |
| 3 | +$16.3K | |
| 4 |
Morgan Stanley
New York
|
+$112 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$16 |
Top Sellers
| 1 | -$106K | |
| 2 | -$92.5K | |
| 3 | -$14.8K | |
| 4 |
NECFA
New England Capital Financial Advisors
Meriden,
Connecticut
|
-$42 |
